CSRIX
Price
$49.09
Change
-$0.39 (-0.79%)
Updated
Oct 6 closing price
Net Assets
7.93B
PRRAX
Price
$28.30
Change
-$0.21 (-0.74%)
Updated
Oct 6 closing price
Net Assets
6.28B
Interact to see
Advertisement

CSRIX vs PRRAX

Header iconCSRIX vs PRRAX Comparison
Open Charts CSRIX vs PRRAXBanner chart's image
Cohen & Steers Instl Realty Shares
Price$49.09
Change-$0.39 (-0.79%)
VolumeN/A
Net Assets7.93B
Principal Real Estate Securities A
Price$28.30
Change-$0.21 (-0.74%)
VolumeN/A
Net Assets6.28B
CSRIX vs PRRAX Comparison Chart in %
View a ticker or compare two or three
VS
CSRIX vs. PRRAX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSRIX is a Buy and PRRAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSRIX has more cash in the bank: 7.93B vs. PRRAX (6.28B). CSRIX pays higher dividends than PRRAX: CSRIX (3.09) vs PRRAX (2.18). CSRIX was incepted earlier than PRRAX: CSRIX (26 years) vs PRRAX (20 years). PRRAX (1.19) is less costly to investors than CSRIX (0.76). PRRAX (31.20) and CSRIX (30.00) have comparable annual turnover. PRRAX has a lower initial minimum investment than CSRIX: PRRAX (1000) vs CSRIX (1000000). CSRIX annual gain was more profitable for investors over the last year : -0.88 vs. PRRAX (-3.62). CSRIX return over 5 years is better than : 36.69 vs. PRRAX (25.50).
CSRIXPRRAXCSRIX / PRRAX
Total Expense Ratio0.751.1963%
Annual Report Gross Expense Ratio0.761.1964%
Fund Existence26 years20 years-
Gain YTD5.7183.154181%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets7.93B6.28B126%
Annual Yield % from dividends3.092.18142%
Returns for 1 year-0.88-3.6224%
Returns for 3 years35.2026.37133%
Returns for 5 years36.6925.50144%
Returns for 10 years41.6648.5886%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HNCRX21.84N/A
N/A
Hartford International Growth R3
VGHCX192.96N/A
N/A
Vanguard Health Care Inv
BQMGX25.25N/A
N/A
Bright Rock Mid Cap Growth Instl
AFDIX58.26N/A
N/A
American Century Large Cap Equity Inv
QRSAX44.27N/A
N/A
FPA Queens Road Small Cap Value Advisor